|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/02 | (2006.01) |
| C12P 21/06 | (2006.01) | ||
| A61K 48/00 | (2006.01) |
| (11) | Number of the document | 3122878 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15767977.0 |
| Date of filing the European patent application | 2015-03-19 | |
| (97) | Date of publication of the European application | 2017-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-24 |
| (46) | Date of publication of the claims translation | 2019-02-11 |
| (86) | Number | PCT/US2015/021403 |
| Date | 2015-03-19 |
| (87) | Number | WO 2015/148247 |
| Date | 2015-10-01 |
| (30) | Number | Date | Country code |
| 201461969483 P | 2014-03-24 | US |
| (72) |
CALIAS, Pericles, US
DEROSA, Frank, US
HEARTLEIN, Michael, US
|
| (73) |
Translate Bio, Inc.,
29 Hartwell Avenue, Lexington, MA 02421,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Terapija mRNR, skirta akių ligų gydymui |
| MRNA THERAPY FOR THE TREATMENT OF OCULAR DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-02-24 | 11 | 289.00 EUR |
| 2026-03-19 |